Cancer research has grown by leaps and bounds over the past few decades. This industry is very exclusive as well as being very demanding. There are numerous cancer research organizations around the world, but one of the best is located in the U.S. This organization is known as Seattle Genetics, and it has helped to transform this dynamic industry for the better. CEO and Founder, Clay Siegall, has been a man on a mission. This extraordinary guy is one of the most accomplished individuals in cancer research. Siegall is known to be a doctor, a scientist, a philanthropist and an author.
Clay Siegall just so happens to be one of the founding-fathers of the company, which dates back to 1998. At the time, Seattle Genetics was just a little startup company that possessed a few clients. The company struggled in the beginning with generating revenue. It basically took up to 10 years before the company would start making large amounts of capital. Operating capital was one of the main issues, but Siegall knew that he had to batten-down the hatches and hire a dynamic sales team. In the early 2000s, Seattle Genetics got its act together because this sales team had pitched a number of the companies products to companies that were in need of cancer-fighting drugs. This sales team has brought the company back from the brink, and it has become the face of Seattle Genetics. Siegall has also been able to instill his core principles into the company. This includes rigorous research, scientific innovation and drug development.
This amazing man has been in this industry for up to 30 years, and he has worked with some of the biggest names in the business. This includes Bristol Myers Squibb, the National Institute of Health and the National Cancer Institute. Seattle Genetics is located in Bothell, Washington, and it has grown into one of today’s leading cancer research institutions.